When primary tumor tissues from GC were tested for their chemotherapeutic sensitivity in vitro, the association between activated AKT and increased resistance to multiple chemotherapeutic agents including 5-fluorouracil, doxorubicin, mitomycin C, and cisplatin was found [16]. The gene discussed is AKT1; the disease is gastric cancer.